Oligo-CALL: A Next-Generation Barcoding Platform for Studying Resistance to Targeted Therapy [bulk RNA-seq]
Single-cell RNA-seq · human · 48 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Samples
- 48 samples: 16 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE299096_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1272565 and SRA study SRP590166. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 48 samples.
How we read this: 16 replicated groups read from 48 sample titles; they account for 48 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9032843 H358 cells, Clone#1, treatment-naïve, vehicle treated, biological replicate 1 H358 cells, Clone#1, tr…
- GSM9032844 H358 cells, Clone#1, treatment-naïve, vehicle treated, biological replicate 2 H358 cells, Clone#1, tr…
- GSM9032845 H358 cells, Clone#1, treatment-naïve, vehicle treated, biological replicate 3 H358 cells, Clone#1, tr…
- GSM9032846 H358 cells, Clone#1, treatment-naïve, AMG510 treated, biological replicate 1 H358 cells, Clone#1, tr…
- GSM9032847 H358 cells, Clone#1, treatment-naïve, AMG510 treated, biological replicate 2 H358 cells, Clone#1, tr…
- GSM9032848 H358 cells, Clone#1, treatment-naïve, AMG510 treated, biological replicate 3 H358 cells, Clone#1, tr…
- GSM9032849 H358 cells, Clone#1, AMG-resistant, Vehicle treated, biological replicate 1 H358 cells, Clone#1, AM…
- GSM9032850 H358 cells, Clone#1, AMG-resistant, Vehicle treated, biological replicate 2 H358 cells, Clone#1, AM…
- GSM9032851 H358 cells, Clone#1, AMG-resistant, Vehicle treated, biological replicate 3 H358 cells, Clone#1, AM…
- GSM9032852 H358 cells, Clone#1, AMG-resistant, AMG510 treated, biological replicate 1 H358 cells, Clone#1, AM…
- GSM9032853 H358 cells, Clone#1, AMG-resistant, AMG510 treated, biological replicate 2 H358 cells, Clone#1, AM…
- GSM9032854 H358 cells, Clone#1, AMG-resistant, AMG510 treated, biological replicate 3 H358 cells, Clone#1, AM…
- GSM9032855 H358 cells, Clone#2, treatment-naïve, vehicle treated, biological replicate 1 H358 cells, Clone#2, tr…
- GSM9032856 H358 cells, Clone#2, treatment-naïve, vehicle treated, biological replicate 2 H358 cells, Clone#2, tr…
- GSM9032857 H358 cells, Clone#2, treatment-naïve, vehicle treated, biological replicate 3 H358 cells, Clone#2, tr…
- GSM9032858 H358 cells, Clone#2, treatment-naïve, AMG510 treated, biological replicate 1 H358 cells, Clone#2, tr…
- GSM9032859 H358 cells, Clone#2, treatment-naïve, AMG510 treated, biological replicate 2 H358 cells, Clone#2, tr…
- GSM9032860 H358 cells, Clone#2, treatment-naïve, AMG510 treated, biological replicate 3 H358 cells, Clone#2, tr…
- GSM9032861 H358 cells, Clone#2, AMG-resistant, Vehicle treated, biological replicate 1 H358 cells, Clone#2, AM…
- GSM9032862 H358 cells, Clone#2, AMG-resistant, Vehicle treated, biological replicate 2 H358 cells, Clone#2, AM…
- GSM9032863 H358 cells, Clone#2, AMG-resistant, Vehicle treated, biological replicate 3 H358 cells, Clone#2, AM…
- GSM9032864 H358 cells, Clone#2, AMG-resistant, AMG510 treated, biological replicate 1 H358 cells, Clone#2, AM…
- GSM9032865 H358 cells, Clone#2, AMG-resistant, AMG510 treated, biological replicate 2 H358 cells, Clone#2, AM…
- GSM9032866 H358 cells, Clone#2, AMG-resistant, AMG510 treated, biological replicate 3 H358 cells, Clone#2, AM…
- GSM9032867 H358 cells, Clone#3, treatment-naïve, vehicle treated, biological replicate 1 H358 cells, Clone#3, tr…
- GSM9032868 H358 cells, Clone#3, treatment-naïve, vehicle treated, biological replicate 2 H358 cells, Clone#3, tr…
- GSM9032869 H358 cells, Clone#3, treatment-naïve, vehicle treated, biological replicate 3 H358 cells, Clone#3, tr…
- GSM9032870 H358 cells, Clone#3, treatment-naïve, AMG510 treated, biological replicate 1 H358 cells, Clone#3, tr…
- GSM9032871 H358 cells, Clone#3, treatment-naïve, AMG510 treated, biological replicate 2 H358 cells, Clone#3, tr…
- GSM9032872 H358 cells, Clone#3, treatment-naïve, AMG510 treated, biological replicate 3 H358 cells, Clone#3, tr…
- GSM9032873 H358 cells, Clone#3, AMG-resistant, Vehicle treated, biological replicate 1 H358 cells, Clone#3, AM…
- GSM9032874 H358 cells, Clone#3, AMG-resistant, Vehicle treated, biological replicate 2 H358 cells, Clone#3, AM…
- GSM9032875 H358 cells, Clone#3, AMG-resistant, Vehicle treated, biological replicate 3 H358 cells, Clone#3, AM…
- GSM9032876 H358 cells, Clone#3, AMG-resistant, AMG510 treated, biological replicate 1 H358 cells, Clone#3, AM…
- GSM9032877 H358 cells, Clone#3, AMG-resistant, AMG510 treated, biological replicate 2 H358 cells, Clone#3, AM…
- GSM9032878 H358 cells, Clone#3, AMG-resistant, AMG510 treated, biological replicate 3 H358 cells, Clone#3, AM…
- GSM9032879 H358 cells, treatment-naïve pool, Vehicle treated, biological replicate 1 H358 cells, treatment-n…
- GSM9032880 H358 cells, treatment-naïve pool, Vehicle treated, biological replicate 2 H358 cells, treatment-n…
- GSM9032881 H358 cells, treatment-naïve pool, Vehicle treated, biological replicate 3 H358 cells, treatment-n…
- GSM9032882 H358 cells, treatment-naïve pool, AMG510 treated, biological replicate 1 H358 cells, treatment-n…
+ 8 more — browse all 48 samples with per-sample file links →
- GSE230601 ZNF397 Deficiency Triggers TET2-driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate Cancer [RNA-seq] 12 samples shares resistance, targeted, therapy
- GSE273829 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [RNA-seq] 92 samples shares resistance, therapy
- GSE286827 4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy 87 samples shares resistance, therapy
- GSE211434 Diverse immune suppressing cancer communications with myeloid cells prevent T cell activation and recruitment and provide resistance to cell cycle inhibitor therapy 81 samples shares resistance, therapy
- GSE312235 Tumors Hijack Immune-Privileging Regulons via Distinct Cell Types to Confer T Cell Desertion and Immunotherapy Resistance Across Various Cancers 72 samples shares resistance, therapy
- GSE300628 HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies 60 samples shares resistance, targeted
- GSE309004 Molecular determinants of neoadjuvant chemotherapy resistance in breast cancer: An analysis of gene expression and tumor microenvironment 54 samples shares resistance, therapy
- GSE289766 Analysis of the mechanism of acquisition of chemotherapy resistance in colorectal cancer cell lines 27 samples shares resistance, therapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.